Acrivon Therapeutics
ACRV
#8030
Rank
NZ$0.36 B
Marketcap
$11.86
Share price
0.30%
Change (1 day)
49.56%
Change (1 year)

Acrivon Therapeutics (ACRV) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.33 Billion

According to Acrivon Therapeutics's latest financial reports the company has NZ$0.33 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Acrivon Therapeutics - Cash on Hand chart (from 2021 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$0.20 B37.99%
2021-12-31NZ$0.14 B6546.68%
2020-12-31NZ$2.19 M